(Q48584309)

English

An open study of remoxipride, a benzamide derivative, in schizophrenia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

An open study of remoxipride, a benzamide derivative, in schizophrenia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

0 references

author name string

L Lindström

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

G Besev

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

G Stening

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

E Widerlöv

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

86

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

1-2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

241-243

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

https://scigraph.springernature.com/pub.10.1007/bf00431718

0 references

Multiple receptors for dopamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2862658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2862658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/2862658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/2862658

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00431718

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/2862658

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48584309&oldid=1381209135"